Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Ames

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Phase I trial of temozolomide (NSC 362856) in patients with advanced cancerM Dhodapkar, J Rubin, J M Reid, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and IIA A Adjei, M Charron, E K Rowinsky, et al.
Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer GroupH S Nicholson, M Krailo, M M Ames, et al.
Leukemia & Lymphoma|December 17, 2002
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer GroupP G Steinherz, N L Seibel, M M Ames, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer GroupH Frangoul, M M Ames, R B Mosher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)E Galanis, R Goldberg, J Reid, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Phase I trial of temozolomide (NSC 362856) in patients with advanced cancerM Dhodapkar, J Rubin, J M Reid, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and IIA A Adjei, M Charron, E K Rowinsky, et al.
Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer GroupH S Nicholson, M Krailo, M M Ames, et al.
Leukemia & Lymphoma|December 17, 2002
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer GroupP G Steinherz, N L Seibel, M M Ames, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer GroupH Frangoul, M M Ames, R B Mosher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)E Galanis, R Goldberg, J Reid, et al.
Pageof 9